Immediate administration of antiviral therapy after transplantation of hepatitis C‐infected livers into uninfected recipients: Implications for therapeutic planning

The practice of transplanting hepatitis C (HCV)‐infected livers into HCV‐uninfected recipients has not previously been recommended in transplant guidelines, in part because of concerns over uncontrolled HCV infection of the allograft. Direct‐acting antivirals (DAAs) provide an opportunity to treat d...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of transplantation 2020-06, Vol.20 (6), p.1619-1628
Hauptverfasser:	Bethea, Emily, Arvind, Ashwini, Gustafson, Jenna, Andersson, Karin, Pratt, Daniel, Bhan, Irun, Thiim, Michael, Corey, Kathleen, Bloom, Patricia, Markmann, Jim, Yeh, Heidi, Elias, Nahel, Kimura, Shoko, Dageforde, Leigh Anne, Cuenca, Alex, Kawai, Tatsuo, Safa, Kassem, Williams, Winfred, Gilligan, Hannah, Sise, Meghan, Fishman, Jay, Kotton, Camille, Kim, Arthur, Rogers, Christin C., Shao, Sarah, Cote, Mariesa, Irwin, Linda, Myoung, Paul, Chung, Raymond T.
Format:	Artikel
Sprache:	eng
Schlagworte:	Allografts Antiviral agents Antiviral Agents - therapeutic use Antiviral drugs Chronic infection clinical research/practice Donors donors and donation: donor‐derived infections Hepacivirus Hepatitis Hepatitis C Hepatitis C - complications Hepatitis C - drug therapy Hepatitis C, Chronic - drug therapy Humans Infections Life Sciences & Biomedicine Liver transplantation liver transplantation/hepatology Liver transplants organ allocation organ procurement and allocation Science & Technology Surgery Tissue Donors Transplantation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!